Partner Kerry Taylor was quoted in “Allergan IP Deal With Tribe Could Have Big Impact On PTAB,” an article published in Law360.
Excerpt: Allergan PLC’s attempt to use a Native American tribe’s sovereign immunity to shield patents for its best-selling eye drug from inter partes review raises new questions for the Patent Trial and Appeal Board and concerns that similar deals could negatively impact the market for generic drugs.
Read Full Article Here >> (Subscription required)